Related Experiment Video
Updated: Jul 18, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status
Sahar Al-Ayyoubi1, Hala Gali-Muhtasib
1Department of Biology, The American University of Beirut, Beirut, Lebanon.
Abstract:
Gallotannin (GT), a plant polyphenol, has shown anticarcinogenic activities in several animal models including colon cancer. In our previous study, we showed that GT inhibits 1,2-dimethylhydrazine-induced colonic aberrant crypt foci and tumors in Balb/c mice, thus supporting a role for GT as a chemopreventive agent in colon cancer. However, at the molecular level, GT's mechanism of chemoprevention is still unclear. In this study, we aim at identifying GT's potential molecular mechanisms of action in in vitro studies. We show that GT differentially inhibits the growth of two isogenic HCT-116 (p53+/+, p53-/-) human colon cancer cells versus normal human intestinal epithelial cells (FHs 74Int). DNA flow cytometric analysis showed that GT induced S-phase arrest in both HCT-116 cell lines. Cell-cycle arrest in p53 (+/+) cells was associated with an increase in p53 protein levels and p21 transcript and protein levels. The inhibition of cell-cycle progression of HCT-116 p53 (+/+) cells by GT correlated with a reduction in the protein levels of cyclin D(1), pRb, and the Bax/Bcl-2 ratio. Although GT did not induce apoptosis in p53 (+/+) cells, a significant induction of apoptosis was observed in p53 (-/-) cells as shown by TUNEL staining and flow cytometry analysis. Apoptosis induction in p53 (-/-) cells was associated with a significant increase in Bax/Bcl-2 protein levels. Our results demonstrate that GT inhibits the growth of HCT-116 colon cancer cells in a p53-independent manner but exhibits differential sensitivity to apoptosis induction in HCT-116 cells with distinct p53 status.
Insights
Gallotannin (GT) inhibits colon cancer cell growth by arresting the cell cycle. It induces apoptosis in p53-deficient cells, revealing its chemopreventive potential through p53-independent mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Natural Products Chemistry
Background:
- Plant polyphenols, like Gallotannin (GT), exhibit anticarcinogenic properties.
- Previous studies indicated GT's efficacy in preventing colon tumors in mice.
- The precise molecular mechanisms underlying GT's chemopreventive effects remain largely unelucidated.
Purpose of the Study:
- To investigate the molecular mechanisms of Gallotannin (GT) in colon cancer chemoprevention.
- To determine GT's effects on human colon cancer cell lines with varying p53 statuses.
- To identify potential molecular targets of GT in colon cancer therapy.
Main Methods:
- Utilized isogenic HCT-116 colon cancer cell lines (p53+/+ and p53-/-) and normal intestinal cells (FHs 74Int).
- Employed DNA flow cytometry to analyze cell-cycle progression and apoptosis.
- Assessed protein and transcript levels of key cell-cycle regulators (p53, p21, cyclin D1, pRb) and apoptosis markers (Bax, Bcl-2).
Main Results:
- GT inhibited the growth of HCT-116 cells and induced S-phase arrest in both p53+/+ and p53-/- lines.
- In p53+/+ cells, GT increased p53 and p21 levels, decreased cyclin D1, pRb, and altered the Bax/Bcl-2 ratio, without inducing apoptosis.
- GT induced significant apoptosis in p53-/- cells, marked by increased Bax/Bcl-2 ratios.
Conclusions:
- Gallotannin (GT) inhibits colon cancer cell proliferation through p53-independent cell-cycle arrest.
- GT demonstrates differential induction of apoptosis based on the p53 status of colon cancer cells.
- These findings support GT's potential as a chemopreventive agent with distinct molecular actions.
More Related Videos
04:20Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Intrinsic Apoptotic Pathway